Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

13,703 total articles

OceanaGold: Deep-Value Long — Own the Mine, Not the Balance Sheet

OceanaGold: Deep-Value Long — Own the Mine, Not the Balance Sheet

OceanaGold (OGC) trades at roughly $5.95B market cap ($26.67/sh) with a low P/E (6.9) and a modest dividend yield. The company runs a clean balance sheet, operates four producing assets across the U.S., New Zealand and the Philippines, and still has upside from development at Haile. Technical indicators are soft, which creates a reasonable entry fo…

Corteva (CTVA) - Buy on Deep Value, Cash Flow and Margin Optionality

Corteva (CTVA) - Buy on Deep Value, Cash Flow and Margin Optionality

Corteva trades at a materially depressed valuation with a roughly $9.16B market cap, >$600M in free cash flow and a near-5% dividend yield. Recent corporate actions (spinoff), margin gains in crop protection, and accommodative balance sheet metrics argue for a long trade around current levels. This is a tactical long: entry $13.50, target $19.00, s…

PayPal's Quiet Rebound - The Turnaround That Starts Outside Checkout

PayPal's Quiet Rebound - The Turnaround That Starts Outside Checkout

PayPal trades at a valuation that assumes persistent checkout weakness. We think the market underestimates alternative growth levers - Venmo monetization, merchant tools, and sustained free cash flow - that can re-rate the stock. This is a mid-term swing trade: enter around $55.00, stop at $49.00, target $72.00 over the next 45 trading days.

Bladex: Capital-Light Pivot and Yield Support Create a Tactical Long

Bladex: Capital-Light Pivot and Yield Support Create a Tactical Long

Bladex (BLX) blends a high-single-digit yield with cheap valuation (PE ~9, PB ~1.3) and improving technicals. We like a tactical long into a potential re-rating as the company leans into capital-light Treasury returns and preserves a healthy dividend. Trade plan: enter $54.80, stop $50.00, target $63.00 over a mid-term 45 trading day horizon.

Owning the Transition: Why Alphabet's AI Stack Could Rebuild the Company

Owning the Transition: Why Alphabet's AI Stack Could Rebuild the Company

Alphabet is aggressively building an end-to-end AI stack — custom TPUs, Gemini models, cloud integration and external compute deals — that could replace legacy search-driven economics with a higher-value AI services franchise. The business is profitable today (EPS $19.96, free cash flow $53.3B) and trades at a reasonable P/E of ~17.6. This trade ta…

Gabon Update Re-Rates Vaalco: A Mid-Stage Swing Trade on Etame Progress

Gabon Update Re-Rates Vaalco: A Mid-Stage Swing Trade on Etame Progress

Vaalco closed a mixed Gabon campaign with a small commercial win (Etame 14H: 4,850 gross BOPD / 2,850 net) after an earlier sidetrack, and the company is moving into the next phase of drilling while Cote d'Ivoire production is set to restart. The shares trade at about $6.00 with a market cap near $632M and EV/EBITDA roughly 6x - attractive if the c…

Synopsys: A Pragmatic Long Trade on AI-Driven Chip Design Momentum

Synopsys: A Pragmatic Long Trade on AI-Driven Chip Design Momentum

Synopsys is uniquely positioned to capture AI-driven demand for custom silicon. Recent strategic deals, investor guidance for revenue up to $11.2B in 2027 and a healthy free cash flow profile make a controlled long trade attractive. Entry at $498, stop at $460 and a target at $580 offers an asymmetric risk-reward over the next 45 trading days.

Nano Nuclear (NNE): Oversold Microreactor Play Backed by Cash, Contracts and Clear Catalysts - Buy the Dip

Nano Nuclear (NNE): Oversold Microreactor Play Backed by Cash, Contracts and Clear Catalysts - Buy the Dip

Nano Nuclear Energy (NNE) has pulled back from its 52-week high and is trading near its 52-week low, but the company still carries meaningful cash, advancing reactor designs, and fresh defense and commercial interest. With a market cap around $807M and enterprise value near $561M, the risk/reward looks favorable for a mid-term swing trade while the…

FANUY: A Tactical Long into Japan’s Robotics Rebound

FANUY: A Tactical Long into Japan’s Robotics Rebound

FANUY (FANUC ADR) has a lot working in its favor right now: strategic commitments to Nvidia’s physical AI push, steady industry tailwinds for robotics and lasers, and improving near‑term technicals. At a market cap near $37B and a P/E around 31x, the stock is not dirt cheap, but recent data and sector catalysts justify a risk‑controlled long with c…

Arbutus at a Crossroads: Buyback + Moderna Settlement Make $ABUS a High-Conviction Long for HBV Success

Arbutus at a Crossroads: Buyback + Moderna Settlement Make $ABUS a High-Conviction Long for HBV Success

Arbutus (ABUS) currently trades at $4.18 with a market cap near $830M. Management’s $230M buyback announcement and the March 2026 Moderna settlement have meaningfully de-risked near-term liquidity and the litigation overhang. Combine that with positive imdusiran clinical signals and an attractive post-settlement valuation, and ABUS looks actionable…

NVDA: Buy the Dip — Nvidia as the AI Infrastructure Backstop

NVDA: Buy the Dip — Nvidia as the AI Infrastructure Backstop

Nvidia remains the indispensable supplier to the AI data center economy. At $232.19 the stock is trading below its 52-week high but still pricing in robust growth. This trade idea sets a mid-term (45 trading days) long with an entry at $232.19, a stop at $213.00, and a target of $290.00 — a risk-managed way to capture continued demand for accelerat…

Amwell's Government Swing: How VA Momentum Could Reprice AMWL Into 2027

Amwell's Government Swing: How VA Momentum Could Reprice AMWL Into 2027

American Well (AMWL) is trading at a market cap near $211M with negative earnings and cash burn, yet a September 2026 Letter of Intent from the Department of Veterans Affairs to deploy Amwell's virtual health platform creates a credible multi-quarter revenue runway. This trade idea buys that government backbone being priced into 2027, with a clearl…